Showing 1 to 2 of 2 results


Dutch Court to Rule on AbbVie's Humira Pricing Lawsuit
A Dutch court will rule on a lawsuit against AbbVie for allegedly making €1 billion in excessive profits from its rheumatoid arthritis drug Humira (adalimumab) between 2004 and 2018; the foundation Farma ter Verantwoording claims this money could have improved the health of 14,000 people.
Dutch Court to Rule on AbbVie's Humira Pricing Lawsuit
A Dutch court will rule on a lawsuit against AbbVie for allegedly making €1 billion in excessive profits from its rheumatoid arthritis drug Humira (adalimumab) between 2004 and 2018; the foundation Farma ter Verantwoording claims this money could have improved the health of 14,000 people.
Progress
52% Bias Score

MSF's Secret Drug Deals Undermine Transparency Campaign
Doctors Without Borders (MSF) signed non-disclosure agreements (NDAs) with pharmaceutical companies, including Bayer, to obtain medicines for low-income countries, contradicting their public advocacy for drug price transparency, due to the power imbalance in supply negotiations.

MSF's Secret Drug Deals Undermine Transparency Campaign
Doctors Without Borders (MSF) signed non-disclosure agreements (NDAs) with pharmaceutical companies, including Bayer, to obtain medicines for low-income countries, contradicting their public advocacy for drug price transparency, due to the power imbalance in supply negotiations.
Progress
44% Bias Score
Showing 1 to 2 of 2 results